Full Text
PCV38 COST-EFFECTIVENESS OF TREATING BY SIMVASTATIN 40 MG/DAY HIGH VASCULAR RISK PATIENTS-AN ECONOMIC EVALUATION BASED ON THE HEART PROTECTION STUDY

Abstract

Authors

F Fagnani A Lafuma T Souchet

Back to Volume 6, Issue 6
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×